These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50 related articles for article (PubMed ID: 7107225)
1. Effect of tauroursodeoxycholic acid on patients with ileal resection. Peled Y; Bar-Meir S; Rotmensch HH; Tiomny A; Gilat T Isr J Med Sci; 1982 Jul; 18(7):812-4. PubMed ID: 7107225 [No Abstract] [Full Text] [Related]
2. [Preliminary observations on the therapeutic use of tauroursodeoxycholate]. Belvisi A; Magnanelli M; Matergi M; Camarri E Clin Ter; 1986 Jun; 117(6):475-9. PubMed ID: 3742969 [No Abstract] [Full Text] [Related]
5. [Is propranolol suitable for the treatment of bile acid-induced diarrhea?]. Simon B; Kather H Med Welt; 1979 Nov; 30(44):1651-3. PubMed ID: 530066 [No Abstract] [Full Text] [Related]
6. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study. Crosignani A; Budillon G; Cimino L; Del Vecchio Blanco C; Loguercio C; Ideo G; Raimondo G; Stabilini R; Podda M Hepatogastroenterology; 1998; 45(23):1624-9. PubMed ID: 9840118 [TBL] [Abstract][Full Text] [Related]
7. Absence of histopathological changes of ileum and colon in functional chronic diarrhea associated with bile acid malabsorption, assessed by SeHCAT test: a prospective study. Sciarretta G; Furno A; Morrone B; Malaguti P Am J Gastroenterol; 1994 Jul; 89(7):1058-61. PubMed ID: 8017365 [TBL] [Abstract][Full Text] [Related]
8. Enterohepatic circulation of bile acids in infants and children with ileal resection. Heubi JE; Balistreri WF; Partin JC; Schubert WK; Suchy FJ J Lab Clin Med; 1980 Feb; 95(2):231-40. PubMed ID: 7354235 [TBL] [Abstract][Full Text] [Related]
9. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006 [TBL] [Abstract][Full Text] [Related]
10. One-year pilot study on tauroursodeoxycholic acid as an adjuvant treatment after liver transplantation. Angelico M; Tisone G; Baiocchi L; Palmieri G; Pisani F; Negrini S; Anselmo A; Vennarecci G; Casciani CU Ital J Gastroenterol Hepatol; 1999; 31(6):462-8. PubMed ID: 10575563 [TBL] [Abstract][Full Text] [Related]
11. Tauroursodeoxycholic acid for the cytoprotection of liver grafts during cold storage: a new aspect of its anti-apoptotic properties? Calmus Y; Podevin P Transplantation; 2001 May; 71(9):1205-6. PubMed ID: 11408962 [No Abstract] [Full Text] [Related]
12. [Spinnability: a new approach to intestinal stress and its therapy]. Droy MT; Drouet Y; Geraud G; Schatz B Gastroenterol Clin Biol; 1985; 9(12 Pt 2):119-21. PubMed ID: 3833604 [No Abstract] [Full Text] [Related]
13. Relationships between the extent of ileal lesion of resection and vitamin B12, bile salt and fat absorption. Papazian A; Minaire Y; Descos L; Andre C; Melange M; Vignal J Hepatogastroenterology; 1981 Apr; 28(2):106-9. PubMed ID: 7216143 [TBL] [Abstract][Full Text] [Related]
14. Effect of tauroursodeoxycholic acid on ALT, GGT and viral load in patients with hepatitis C virus-related chronic hepatitis with reference to the genotype. Belloni G; Ferrari L; Balduzzi C; Barbieri F; Insolia R; Klersy C Ital J Gastroenterol Hepatol; 1999; 31(5):427. PubMed ID: 10470605 [No Abstract] [Full Text] [Related]
15. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture. Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437 [TBL] [Abstract][Full Text] [Related]
16. Factors in the mechanism of diarrhea in bile acid malabsorption: fecal pH--a key determinant. McJunkin B; Fromm H; Sarva RP; Amin P Gastroenterology; 1981 Jun; 80(6):1454-64. PubMed ID: 7227771 [No Abstract] [Full Text] [Related]
17. Mucosal function in rat jejunum and ileum is altered by induction of colitis. Amit-Romach E; Reifen R; Uni Z Int J Mol Med; 2006 Oct; 18(4):721-7. PubMed ID: 16964428 [TBL] [Abstract][Full Text] [Related]
18. Does tauroursodeoxycholic acid (TUDCA) treatment increase hepatocyte proliferation in patients with chronic liver disease? Panella C; Ierardi E; De Marco MF; Barone M; Guglielmi FW; Polimeno L; Francavilla A Ital J Gastroenterol; 1995 Jun; 27(5):256-8. PubMed ID: 8541578 [TBL] [Abstract][Full Text] [Related]
19. Bile acid-induced secretion in polarized monolayers of T84 colonic epithelial cells: Structure-activity relationships. Keely SJ; Scharl MM; Bertelsen LS; Hagey LR; Barrett KE; Hofmann AF Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G290-7. PubMed ID: 16901996 [TBL] [Abstract][Full Text] [Related]
20. Tauroursodeoxycholic acid administration as adjuvant therapy in cirrhotic patients on transplantation waiting lists. Caglieris S; Giannini E; Dardano G; Mondello L; Valente U; Testa R Hepatogastroenterology; 2000; 47(34):1045-7. PubMed ID: 11020875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]